» Articles » PMID: 20609227

Localized 1H-NMR Spectroscopy in Patients with Fibromyalgia: a Controlled Study of Changes in Cerebral Glutamate/glutamine, Inositol, Choline, and N-acetylaspartate

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2010 Jul 9
PMID 20609227
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The purpose of this study was to investigate whether single-voxel (SV) proton magnetic resonance spectroscopy (MRS), diffusion-weighted imaging (DWI), and diffusion tensor imaging (DTI) detected differences between fibromyalgia (FM) patients and healthy controls. We also searched for correlations between neuroimaging abnormalities and neuropsychological variables.

Methods: Ten patients with FM and 10 gender- and age-matched control subjects were studied. A neuropsychological examination, DWI, DTI, and proton MRS were performed on the brain areas known to be associated with pain processing.

Results: Compared with healthy controls, FM patients had significantly higher levels of glutamate + glutamine (Glx) (mean ± SD, 10.71 ± 0.50 arbitrary institutional units versus 9.89 ± 1.04; P = 0.049) and higher glutamate + glutamine/creatine (Glx/Cr) ratios (1.90 ± 0.12 versus 1.72 ± 0.23; P = 0.034) in the posterior gyrus. Myoinositol (Ins) levels of the right and left hippocampi were significantly lower in FM patients (4.49 ± 0.74 versus 5.17 ± 0.62; P = 0.008 and 4.91 ± 0.85 versus 6.09 ± 0.78; P = 0.004, respectively). In FM patients, decreased myoinositol/creatine (Ins/Cr) ratios were found in the left sensorimotor area (P = 0.05) and the left hippocampus (P = 0.002) and lower levels of choline (P = 0.019) and N-acetyl aspartate + N-acetyl aspartyl glutamate (NAA + NAG) (P = 0.034) in the left hippocampus. Significant correlations between depression, pain, and global function and the posterior gyrus Glx levels and Glx/Cr ratios were observed.

Conclusions: Glx within the posterior gyrus could be a pathologic factor in FM. Hippocampal dysfunction may be partially responsible for the depressive symptoms of FM. Additional studies with larger samples are required to confirm these preliminary data.

Citing Articles

Serum choline, leptin and interleukin-6 levels in fibromyalgia syndrome-induced pain: a case-control study.

Baris E, Topaloglu I, Akalin E, Hamurtekin E, Kabaran S, Gelal A BMC Musculoskelet Disord. 2025; 26(1):97.

PMID: 39893410 PMC: 11786483. DOI: 10.1186/s12891-025-08337-0.


What has brain diffusion magnetic resonance imaging taught us about chronic primary pain: a narrative review.

Bautin P, Fortier M, Sean M, Little G, Martel M, Descoteaux M Pain. 2025; 166(2):243-261.

PMID: 39793098 PMC: 11726505. DOI: 10.1097/j.pain.0000000000003345.


Neuroimaging and artificial intelligence for assessment of chronic painful temporomandibular disorders-a comprehensive review.

Shrivastava M, Ye L Int J Oral Sci. 2023; 15(1):58.

PMID: 38155153 PMC: 10754947. DOI: 10.1038/s41368-023-00254-z.


Pain Biomarkers in Fibromyalgia Syndrome: Current Understanding and Future Directions.

Favretti M, Iannuccelli C, Di Franco M Int J Mol Sci. 2023; 24(13).

PMID: 37445618 PMC: 10341963. DOI: 10.3390/ijms241310443.


Orally Administered Bifidobacterium adolescentis Diminishes Serum Glutamate Concentration in Mice.

Royo F, Tames H, Bordanaba-Florit G, Cabrera D, Azparren-Angulo M, Garcia-Vallicrosa C Microbiol Spectr. 2023; 11(4):e0506322.

PMID: 37347184 PMC: 10433951. DOI: 10.1128/spectrum.05063-22.


References
1.
Harwood A . Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiatry. 2004; 10(1):117-26. DOI: 10.1038/sj.mp.4001618. View

2.
Ogura A, Miyamoto M, Kudo Y . Neuronal death in vitro: parallelism between survivability of hippocampal neurones and sustained elevation of cytosolic Ca2+ after exposure to glutamate receptor agonist. Exp Brain Res. 1988; 73(3):447-58. DOI: 10.1007/BF00406601. View

3.
Garcia-Campayo J, Fayed N, Serrano-Blanco A, Roca M . Brain dysfunction behind functional symptoms: neuroimaging and somatoform, conversive, and dissociative disorders. Curr Opin Psychiatry. 2009; 22(2):224-31. DOI: 10.1097/YCO.0b013e3283252d43. View

4.
Cordoba J, Sanpedro F, Alonso J, Rovira A . 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis. 2003; 17(4):415-29. DOI: 10.1023/a:1021926405944. View

5.
Gracely R, Petzke F, Wolf J, Clauw D . Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002; 46(5):1333-43. DOI: 10.1002/art.10225. View